Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
TollBit is a content monetization platform that allows AI bots and data scrapers to pay for content instead of scraping data from websites.
Basecamp Research leverages their unprecedented knowledge of the natural world to create better medicines, better food and better products
Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.
Ema uses AI-powered agents to automate tasks in HR, customer support, and data management, making enterprise workflows more efficient.
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.
Brightside Health is a telemedicine platform integrating precision psychiatry with advanced therapeutic techniques.
Neocis develops robot-assisted dental implant surgery with the aim of transforming dental surgery using advanced robotics.
Puzzle Financial is a modern data platform for startups
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.
Inworld AI is an AI runtime powering massive consumer applications.
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
MedArrive is a healthcare logistics platform that connects patients with on-demand medical transportation and care.
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.
Outtake is a digital trust platform automating threat classification, detection, and response to enhance enterprise cybersecurity measures.
Forward Networks builds digital twins, transforming networks to be more agile, reliable, and secure via math modeling.
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
humans& operates as a frontier artificial intelligence research and product lab focused on human-centered AI systems and interaction models.
Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Teckro is a life science technology company that is rethinking every element of clinical research.
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Metaphysic specializes in AI-generated, photorealistic content for entertainment, offering tools to protect digital likeness rights.
S32 has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
S32's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Machine Learning, Therapeutics. The firm invests across 43 different industry categories.
Among tracked funding rounds, humans& received $480.0M in a Seed round. S32's total known invested capital is $4.6B.
S32's average investment size is $50.0M across its portfolio of 102 companies.
Recent S32 portfolio additions include TollBit, Basecamp Research, Nusano, Ema, Nucleai. These companies were founded in 2020 or later.